Results 141 to 150 of about 98,670 (206)

Preclinical pharmacology of alogabat: a novel GABA_A-α5 positive allosteric modulator targeting neurodevelopmental disorders with impaired GABA_A signaling. [PDF]

Front Pharmacol
Cecere G, Ballard TM, Knoflach F, Honer M, Hipp JF, Garces P, Mueggler T, Künnecke B, Bruns A, Prinssen EP, Schoenenberger P, Janz P, Redondo R, Biemans B, Knust H, Olivares-Morales A, Brigo A, Schulz JM, Bertrand D, Saxe M, O'Connor EC, Hernandez MC.   +21 more
europepmc   +1 more source

Study of conditions to evaluate light hypersensitivity in a light-dark box using a mouse model and a mydriatic. [PDF]

PCN Rep
Hirota S, Gotoh L, Hayashi R, Kitai Y, Matsuoka H, Masuda M, Kawasaki H, Hori H.   +7 more
europepmc   +1 more source

Selection of an Optimal Metabolic Model for Accurately Predicting the Hepatic Clearance of Albumin-Binding-Sensitive Drugs. [PDF]

Pharmaceuticals (Basel)
Liang RJ, Hsu SH, Chen HT, Chen WH, Fu HY, Chen HY, Wang HJ, Tang SL.   +7 more
europepmc   +1 more source

Tracking Epidermal Cortisol and Oxytocin in Managed Bottlenose Dolphins as Potential Non-Invasive Physiological Welfare Indicators. [PDF]

Animals (Basel)
Agustí C, Talló-Parra O, Tejero-Caballo E, Garcia-Parraga D, López-Arjona M, Álvaro-Álvarez T, Joaquín-Cerón J, Manteca X.   +7 more
europepmc   +1 more source

Effect of Lemborexant-Based Sleep Medication Formulary on Benzodiazepine Reduction and Clinical Outcomes: A Single-Center Retrospective Study. [PDF]

Neuropsychopharmacol Rep
Aoki S, Takada K, Sugama T, Kimiwada M, Hoshino T, Koike K, Akada H, Saiga T, Sato S, Shinkai R, Shibata Y, Tomita T.   +11 more
europepmc   +1 more source